The p53 Slavic Gene Mutation Nijmegen Breakage Syndrome

Nijmegen breakage syndrome is a rare autosomal congenital disorder. It originates from mutations in the NBS1 gene located in band 8q21, which encodes for the DNA double strand repair protein Nibrin. Immunodeficiency with increased susceptibility to infection. It is a condition characterized by short stature, an unusually small head size (microcephaly), distinctive facial features, recurrent respiratory tract infections, an increased risk of cancer, intellectual disability, and other health problems. People with this condition typically grow slowly during infancy and early childhood. After this period of slow growth, affected individuals grow at a normal rate but remain shorter than their peers. Microcephaly is apparent from birth in the majority of affected individuals. The head does not grow at the same rate as the rest of the body, so it appears that the head is getting smaller as the body grows (progressive microcephaly).Individuals with Nijmegen breakage syndrome have distinctive facial features that include a sloping forehead, a prominent nose, large ears, a small jaw, and outside corners of the eyes that point upward (up slanting palpebral fissures). These facial features typically become apparent by age 3.

Epidemiology: Nijmegen breakage syndrome is a rare disease and there are no reliable estimates of its prevalence. The largest groups of patients were West Slavic origins diagnosed in Poland, Czech Republic, Ukraine and some parts of Russia. The number of known patients identified worldwide increased significantly when the disease-causing gene, NBN, was identified. Apart from over 150 subjects reported in the medical literature , there are many more patients recorded in national registries (e.g. Czech and Polish-CKH p.c.). Currently, the largest European registry is Page: 2 www.raftpubs.com managed by the European Society for Immunodeficiencies (ESID). The disease seems to occur worldwide, but with a distinctly higher prevalence among Central European and Eastern European populations, i.e. in the Czech Republic, Poland, Russia and Ukraine. The proportion of patients identified in these populations correlates with a high carrier frequency of the major NBN mutation, c.657_661del5, estimated to be 1 case per 177 newborns, clearly the result of a founder effect. Nijmegen breakage syndrome has also been reported in many other European countries as well as in North and South America, Morocco and New Zealand. Page: 3 www.raftpubs.com Typical facial features in an 8-year-old boy with microcephaly, long prominent nose, and small chin.

Treatment: No specific therapy is available
for NBS. Due to the specific basic defect underlying immunodeficiency and sensitivity to IR, patients with NBS require multidisciplinary medical management and long-term follow-up. Specialized care provided by clinicians aware of these problems and of the natural history of the disease can prevent some complications, avoid unnecessary and excessive exposition to IR and take into consideration the high risk for malignancy. MRI and ultrasound examination are recommended as imaging techniques rather than CT scan or X-ray. It is important that patients with NBS are under the care of one primary physician, preferably a pediatrician or a general practitioner, who is acquainted with the condition. Systematic (prophylactic) supervision by an immunologist and oncologist is recommended. Female patients should be under the care of an endocrinologist and a gynecologist when they reach pubertal age. Psychological, social and educational support is essential for improvement of the quality of patients' life.
Substitution with immunoglobulins (i.e., [IVIG] therapy) is indicated in patients with agammaglobulinemia and in children with IgG2 deficiency. Before IVIG is started, the presence of anti-IgA antibodies must be determined in patients with IgA deficiency. Consider antibiotic prophylaxis in patients with recurrent respiratory tract infections. Urinary tract infections due to congenital malformations of the kidneys occur in some children; antibiotic prophylaxis is indicated in these patients. The intensity of therapy must be adapted to individual risk factors and tolerance. Anthracycline-induced cardiomyopathy was reported in one patient, and, therefore, echocardiographic monitoring is strongly recommended. Bone marrow transplantation (BMT) or hematopoietic stem cells transplantation (HSCT) is an option that can be considered in some patients with Nijmegen breakage syndrome. When hypergonadotropic hypogonadism is confirmed, substitution hormone therapy to support the development of secondary sex characteristics and to prevent osteoporosis must be considered when the patient reaches the appropriate age.
Vitamin E supplementation in doses appropriate for age and body weight is recommended, as in individuals with other chromosome instability disorders. Page: 4 www.raftpubs.com

Conclusion
Because patients with NBS have an increased risk of developing malignancies, it is important to diagnose this disease at an early age. In NBS patients x irradiation should be avoided as much as possible, for therapeutic but also for diagnostic reasons. In all patients with unexplained early progressive microcephaly and growth retardation, chromosome instability analysis should be performed, in order to establish or exclude a chromosome instability disorder.